Clinical Trial

Application-Assisted Weight Management in Endometrial Cancer Fertility Preservation

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is a single-center, prospective, randomized controlled trial targeting endometrial cancer (EC) patients undergoing fertility-sparing treatment at Peking University People's Hospital from March 2025 to March 2027. The aim is to evaluate the efficacy of an intelligent mobile application (APP) based on the Adaptive Behavioral Intervention (ABI) framework in weight management for obese or overweight endometrial cancer patients receiving fertility preservation therapy. Additionally, the study seeks to explore its potential advantages in improving body mass index (BMI), tumor regression, and glucose and lipid metabolism profiles.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-24.
Trial Details
NCT Number NCT06901778
Lead Sponsor Peking University People's Hospital
Conditions Endometrial Cancer, Mobile Applications, Weight Management
Enrollment 106 participants
Start Date 2025-03-31
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-03